Thomas Langan Sells 51,537 Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Stock


Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX – Get Rating) insider Thomas Langan sold 51,537 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Tuesday, May 10th. The shares were sold at an average price of $18.12, for a total value of $933,850.44. Following the sale, the insider now directly owns 139,912 shares in the company, valued at approximately $2,535,205.44. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

NASDAQ MDRX opened at $17.83 on Thursday. The company has a market cap of $2.06 billion, a P/E ratio of 15.92, a P/E/G ratio of 1.67 and a beta of 0.98. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.39 and a current ratio of 1.39. The business’s 50 day moving average price is $21.57 and its 200-day moving average price is $19.21. Allscripts Healthcare Solutions, Inc. has a fifty-two week low of $13.05 and a fifty-two week high of $23.25.

Allscripts Healthcare Solutions (NASDAQ:MDRX – Get Rating) last released its earnings results on Thursday, May 5th. The software maker reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.03). Allscripts Healthcare Solutions had a net margin of 11.60% and a return on equity of 10.86%. The company had revenue of $142.70 million for the quarter, compared to the consensus estimate of $139.67 million. During the same period in the prior year, the firm posted $0.13 EPS. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. As a group, equities analysts predict that Allscripts Healthcare Solutions, Inc. will post 0.69 EPS for the current year.

Institutional investors and hedge funds have recently bought and sold shares of the stock. C M Bidwell & Associates Ltd. purchased a new position in Allscripts Healthcare Solutions during the 1st quarter valued at $44,000. Maverick Capital Ltd. purchased a new position in Allscripts Healthcare Solutions during the 3rd quarter valued at $55,000. AdvisorShares Investments LLC purchased a new position in Allscripts Healthcare Solutions during the 1st quarter valued at $186,000. Hightower 6M Holding LLC purchased a new position in Allscripts Healthcare Solutions during the 1st quarter valued at $225,000. Finally, Inspire Investing LLC purchased a new position in Allscripts Healthcare Solutions during the 1st quarter valued at $235,000.

MDRX has been the topic of a number of research reports. Piper Sandler reduced their price objective on Allscripts Healthcare Solutions from $22.00 to $19.00 in a research note on Friday, May 6th. Deutsche Bank Aktiengesellschaft raised Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $20.00 to $26.00 in a research note on Friday, March 4th. Zacks Investment Research downgraded Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating and set a $23.00 price objective on the stock. in a research note on Tuesday, March 29th. StockNews.com downgraded Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research note on Monday, May 2nd. Finally, TheStreet downgraded Allscripts Healthcare Solutions from a “b” rating to a “c” rating in a research note on Friday, May 6th. Four investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $22.00.

About Allscripts Healthcare Solutions (Get Rating)

Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Articles

Insider Buying and Selling by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)



Receive News & Ratings for Allscripts Healthcare Solutions Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com’s FREE daily email newsletter.

#Thomas #Langan #Sells #Shares #Allscripts #Healthcare #Solutions #NASDAQMDRX #Stock

Leave a Reply

Your email address will not be published.